Sammann Derek 4
Research Summary
AI-generated summary
CME Group (CME) Sr. MD Derek Sammann Receives Performance Award
What Happened
- Derek Sammann, Senior Managing Director, Global Head of Commodities Markets, received a performance-based award of 8,256 CME Group shares on 2026-03-15 valued at $311.40 each (total value reported: $2,570,918). To satisfy tax withholding related to the award, 3,627 shares were surrendered to the company (value reported: $1,129,448). Net shares delivered to Sammann = 4,629 shares (approx. $1,441,471 based on the reported per-share value).
- This was an award/vesting event (code A) with a simultaneous tax-withholding disposition (code F), not an open-market purchase or sale.
Key Details
- Transaction dates: 2026-03-15 (reported on Form 4 filed 2026-03-17).
- Prices and values reported: $311.40 per share; 8,256 shares = $2,570,918 (award); 3,627 shares = $1,129,448 (withheld).
- Net shares retained: 4,629 shares (approx. $1,441,471).
- Footnotes: The shares represent vesting of 2022 performance shares under CME’s Omnibus Stock Plan, with the final payout determined by total shareholder return vs. the S&P 500 for the 2023–2025 performance period. Sammann surrendered shares to cover tax withholding obligations.
- Filing timeliness: Form 4 dated 2026-03-17 for a 2026-03-15 event appears to have been filed within the standard Form 4 reporting window.
- Shares owned after the transaction: Not specified in the material provided.
Context
- This was a compensation-related vesting of performance shares, not an open-market purchase or routine sale; the surrender of shares to cover taxes is common and does not itself indicate a change in investment view.
- For retail investors, awards reflect company compensation outcomes (here tied to three-year TSR relative to the S&P 500) rather than a direct buy/sell signal from the insider.